We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · May 14, 2020

Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and Vomiting

JAMA Oncology

 

Additional Info

JAMA Oncology
Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial
JAMA Oncol 2020 May 07;[EPub Ahead of Print], RM Navari, CM Pywell, JG Le-Rademacher, P White, AB Dodge, C Albany, CL Loprinzi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading